2nd Quarter - Report
W STRATEGIES, LLC for MERCK & CO., INC.
Firm
Client
Income
$50,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
FY '22 Budget Reconciliation, including H.R.3: Elijah E. Cummings Lower Drug Costs Now Act, and H.R.19: Lower Costs, More Cures Act of 2021.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Health Issues HCR
S.4348: FDASLA Act of 2022 and H.R.7667: Food and Drug Amendments of 2022. Education around antibiotic resistance.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.